Adenocarcinoma in situ of the cervix - Controversies in diagnosis and treatment

Journal of Lower Genital Tract Disease

Volumn 5, Issue 2, 2001, Pages 94-98

  Etherington, Ian J ^a   Luesley, David M ^b  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adenocarcinoma in situ; Screening

Indexed keywords

CLINICAL TRIAL; COLPOSCOPY; CURETTAGE; DIAGNOSTIC VALUE; FEMALE; FEMALE GENITAL TRACT CYTOLOGY; FERTILITY; FOLLOW UP; GYNECOLOGIC SURGERY; HUMAN; PAPANICOLAOU TEST; PATHOLOGICAL ANATOMY; PATIENT SATISFACTION; RECURRENT DISEASE; REVIEW; SCREENING TEST; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE ENDOCERVIX;

EID: 0034996295     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0976.2001.005002094.x     Document Type: Review

References (27)

1. Laara E, Day N E, Hakama M. Trends in mortality from cervical cancer in the nordic countries: association with organised screening programmes. Lancet 1987;1(8544):1247-9.
2. Nieminen P, Kallio M, Hakama M. The effect of mass screening on the incidence and mortality of squamous and adenocarcinoma of the cervix uteri. Obstet Gynecol 1995;85: 1017-20.
3. Christopherson WM, Nealson N, Gray LA. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979;44:975-83.
4. Boon ME, Baak JPA, Kurver PJH, et al. Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer 1981;48:768-773.
5. Qizilbash AH. In situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologie and histologie study of 14 cases. Am J Clin Pathol 1975;64:155-170.
6. Ostor AG, Pagano R, Davoren RAM, Fortune DW, Chanen W, Rome R. Adenocarcinoma in situ of the cervix, bit J Gynecol Pathol 1984;3:179-190.
7. Luesley DM, Jordan JA, Woodman CBJ, Watson N, Williams DR, Waddell C. A retrospective review of adenocarcinoma-in-situ and glandular atypia of the uterine cervix. Br J Obsts Gyiiaecol 1987;94:699-703.
8. Bertrand M, Lickrish GM, Colgan TJ. The anatomic distribution of cervical adenocarcinoma-in-situ: implications for treatment. Am J Obstet Gynecol 1987;157:21-5.
9. Hopkins MP, Roberts JA, Schmidt RW. Cervical adenocarcinoma in situ. Obstet Gynecol 1988;71:842-4.
10. Jaworski RC, Pacey NF, Greenberg ML, Osborn RA. The histologie diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Cancer 1988;61:1171-81.
11. Andersen ES, Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinico-pathological study of 36 cases. Gy;zeco/OHCo/1989;35:l-7.
12. Nicklin JL, Wright RG, Bell JR, et al. A clinicopathological study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery. Anst NZ J Obstet Gynaecol 1991;31: 179-83.
13. Muntz HG, Bell DA, Lage JM, et al. Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol 1992;80:935-9.
14. Poynor EA, Barakat RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1994;57:158-64.
15. Im DD, Duska LR, Rosenshein NB. Adequacy of coniza-tion margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 1995;59:179-82.
16. Wildrich T, Kennedy AW, Myers TM, Hart WR, Wirth S. Adenocarcinoma in situ of the uterine cervix: management and outcome. Gynecol Oncol 1996;61:304-8.
17. Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol 1996;88:82-6.
18. Cullimore JE, Luesley DM, Rollason TP, et al. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN) - a preliminary report. BrJ Obsts Gynaecol 1992;99:314-8 .
19. Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F. ThinPrep Pap Test. Accuracy for glandular disease. Ada Cytologica 1999;43(l):81-5.
20. Roberts JM, Thurloe JK, Bowditch RC, Humcevic J, Laverty CR. Comparison of ThinPrep and Pap smear in relation to prediction of adenocarcinoma in situ. Acta Cytologica 1999;43(1):74-80.
21. Wright VC. Colposcopy of adenocarcinoma in situ and adencarcinoma of the uterine cervix: differentiation from other cervical lesions./ Lower Gen Tract Dis 1999;3:83-97.
22. Muntz HG. Can cervical adenocarcinoma in situ be safely managed by conization alone? Gynecol Oncol 1996;61: 301-3.
23. Kurian K, al-Nafussi A. Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: a study of 121 cases./ Clin Pathol1999;52(2):lU-7.
24. Goldstein NS, Mani A. The status and distance of cone biopsy margins as a predictor of excision adequacy for adenocarcinoma in situ. Am J Clin Pathol 1998;109(6):727-32.
25. Denehy TR, Gregori CA, Breen JL. Endocervical curettage, cone margins and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1997;90:l-6.
26. Kennedy AW, El Tabbakh GH, Biscotti CV, Wirth S. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 1995;58:274-7.
27. Houghton SJ, Shafi MI, Rollason TP, Luesley DM. Is loop excision adequate primary treatment of adenocarcinoma in situ of the cervix? BrJ Obstet Gynaecol 1997;104:325-9.